{"id":"W2155339274","doi":"10.1586/17474124.1.1.29","title":"Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn’s disease","year":2007,"lang":"en","type":"review","venue":"Expert Review of Gastroenterology & Hepatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natalizumab; Medicine; Progressive multifocal leukoencephalopathy; Crohn's disease; Multiple sclerosis; Adverse effect; Disease; Clinical trial; Internal medicine; Immunology; Inflammatory bowel disease; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009744648,0.0007748204,0.002181295,0.001909671,0.0002503865,0.0008171141,0.0007706706,0.001097406,0.002553681],"category_scores_gemma":[0.0009351693,0.000302571,0.0005298586,0.002292604,0.0003967495,0.0008880147,0.0004482237,0.001259628,0.001522235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004991602,"about_ca_system_score_gemma":0.0007728773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001041018,"about_ca_topic_score_gemma":0.002341328,"domain_scores_codex":[0.9996743,0.00007051881,0.00005973222,0.00004569802,0.0001312143,0.00001850817],"domain_scores_gemma":[0.9996075,0.0001780848,0.00007938525,0.000009420719,0.00009471722,0.00003091915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001412793,0.00005169624,0.0001865784,0.01614103,0.0001085182,0.0001767565,0.0000432883,0.0001776044,0.001579817,0.0006552447,0.01168393,0.9690542],"study_design_scores_gemma":[0.000155471,0.0004388648,0.003999709,0.007931311,0.0004857244,0.004653526,0.00008692047,0.0001829012,0.00130655,0.001391718,0.9793315,0.00003566801],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001373696,0.9992962,0.00004909374,0.0001173489,0.00004195499,0.000003119471,0.000006009228,0.000003526725,0.0003453435],"genre_scores_gemma":[0.0009520501,0.9984755,0.0001226792,0.0001084247,0.00007856691,0.000005487326,0.00001164411,0.000001004364,0.0002446791],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002553681,"threshold_uncertainty_score":0.008542895,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04087326896036397,"score_gpt":0.4174814094763494,"score_spread":0.3766081405159854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}